IN THIS ISSUE

Ed Silverman
There are not many traditional medications in the pipeline, and those that are in development probably won’t make waves
Lola Butcher
Plans prod hospitals to do a better job of addressing problems that kill nearly 100,000 Americans a year
Editor's Memo
John Marcille
Legislation & Regulation
John Carroll
The Empire State’s approach to physician ratings quickly gains health plan support and consideration as a national answer
Medication Management
Martin Sipkoff
Programs that include a pharmacology benefit reap rewards for the health plan and the member. So why isn’t there 100 percent buy-in?
Tomorrow's Medicine
Thomas Morrow, MD
Evithrom may minimize some of the antibody production associated with bovine proteins, but the possibility of human viral infection exists
Lola Butcher
Many new programs offered by insurers bet that individuals, not employers, will one day be making the major decisions
News and Commentary